Skip to main content
    Q

    Qiagen NV (QGEN)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $49.80
    -0.09 (-0.18%)

    Market Cap: $10.30B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Qiagen NV (QGEN) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Qiagen NV are Charles River Laboratories (CRL), ICON (ICLR) and Revvity (RVTY). Qiagen NV trades at 20.5x earnings, against a median of 33.8x for the 10 of these companies with a P/E. By market cap, Qiagen NV ranks 8th of the 13 companies on this page; IQVIA Holdings (IQV) is the largest at $43.69B.

    Peer Comparison

    QGEN's ROIC of 8.2% is above the peer median of 3.1%, and its revenue growth of 2.9% is below the median of 6.2%. It yields 0.70%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Qiagen NV (QGEN)$10.30B20.5x4.9x18.2%8.2%2.9%0.70%
    Charles River Laboratories (CRL)$16.19B31.8x4.0x1.0%0.1%-2.2%0.00%
    ICON PLC (ICLR)$14.58B20.0x1.8x5.3%2.8%-2.9%0.00%
    Revvity Inc. (RVTY)$17.24B26.8x5.6x8.6%3.4%4.3%0.19%
    GRAIL, LLC (GRAL)$5.21BN/A29.6x-243.8%N/A3.7%0.00%
    IQVIA Holdings Inc (IQV)$43.69B22.0x2.5x8.1%8.5%8.0%0.00%
    Illumina Inc (ILMN)$31.30B37.7x6.6x19.7%19.1%4.2%0.00%
    Quest Diagnostics Incorporated (DGX)$28.56B23.8x2.4x9.5%10.2%10.0%1.31%
    RadNet Inc (RDNT)$6.02B141.5x2.5x-0.9%2.7%22.1%0.00%
    Adaptive Biotechnologies Corp (ADPT)$4.70BN/A15.0x-23.7%N/A-10.7%0.00%
    Medpace Holdings Inc (MEDP)$18.29B35.9x6.4x18.2%N/A8.5%0.00%
    CareDx Inc (CDNA)$4.09B48.2x6.4x25.9%N/A39.3%0.00%
    NeoGenomics Inc (NEO)$2.07B228.9x2.6x-4.1%-2.5%11.4%0.00%
    Peer median$15.39B33.8x4.8x6.7%3.1%6.2%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Qiagen NV, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Diagnostics & Research.

    CompanyAboutPeers
    Charles River Laboratories (CRL)
    Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory...
    CRL competitors
    ICON PLC (ICLR)
    ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe...
    ICLR competitors
    Revvity Inc. (RVTY)
    Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally.
    RVTY competitors
    GRAIL, LLC (GRAL)
    GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics...
    GRAL competitors
    IQVIA Holdings Inc (IQV)
    IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology...
    IQV competitors
    Illumina Inc (ILMN)
    Illumina, Inc. is an American company.
    ILMN competitors
    Quest Diagnostics Incorporated (DGX)
    Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil.
    DGX competitors
    RadNet Inc (RDNT)
    RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.
    RDNT competitors
    Adaptive Biotechnologies Corp (ADPT)
    Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
    ADPT competitors
    Medpace Holdings Inc (MEDP)
    Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
    MEDP competitors
    CareDx Inc (CDNA)
    CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally.
    CDNA competitors
    NeoGenomics Inc (NEO)
    NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia.
    NEO competitors

    Frequently Asked Questions About QGEN

    Who are Qiagen NV's main competitors?

    The companies most similar to Qiagen NV include Charles River Laboratories (CRL), ICON (ICLR), Revvity (RVTY), GRAIL, LLC (GRAL) and IQVIA Holdings (IQV), listed from the closest match.

    Who is Qiagen NV's biggest competitor?

    IQVIA Holdings (IQV) is the largest of the similar companies at $43.69B; Charles River Laboratories (CRL) is the closest match by business profile, size, sector and industry.

    How does QGEN stock compare with its competitors?

    QGEN's P/E is 20.5x against a peer median of 33.8x; its P/S is 4.9x against a peer median of 4.8x; its net margin is 18.2% against a peer median of 6.7%.

    Which of Qiagen NV's competitors pays a higher dividend?

    Qiagen NV has a forward dividend yield of 0.70%. Quest Diagnostics (DGX) has a higher forward dividend yield; Quest Diagnostics (DGX) has the highest at 1.31%.

    Is Qiagen NV bigger than its competitors?

    No. Qiagen NV is 8th by market cap among the 13 companies on this page; the largest is IQVIA Holdings (IQV) at $43.69B.